NSEI:BAYERCROP

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India. More Details


Snowflake Analysis

Outstanding track record with excellent balance sheet and pays a dividend.


Similar Companies

Share Price & News

How has Bayer CropScience's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BAYERCROP has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-5.7%

BAYERCROP

-4.6%

IN Chemicals

-4.3%

IN Market


1 Year Return

78.3%

BAYERCROP

14.1%

IN Chemicals

-1.6%

IN Market

Return vs Industry: BAYERCROP exceeded the Indian Chemicals industry which returned 13% over the past year.

Return vs Market: BAYERCROP exceeded the Indian Market which returned -4.4% over the past year.


Shareholder returns

BAYERCROPIndustryMarket
7 Day-5.7%-4.6%-4.3%
30 Day-3.2%-3.0%-4.2%
90 Day0.5%12.9%6.6%
1 Year81.9%78.3%16.7%14.1%0.2%-1.6%
3 Year58.2%53.6%41.7%33.5%1.9%-3.0%
5 Year70.4%64.2%132.4%113.1%38.6%28.4%

Price Volatility Vs. Market

How volatile is Bayer CropScience's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Bayer CropScience undervalued compared to its fair value and its price relative to the market?

45.62x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: BAYERCROP (₹5990.6) is trading above our estimate of fair value (₹1730.74)

Significantly Below Fair Value: BAYERCROP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: BAYERCROP is poor value based on its PE Ratio (45.6x) compared to the IN Chemicals industry average (14.8x).

PE vs Market: BAYERCROP is poor value based on its PE Ratio (45.6x) compared to the Indian market (15.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BAYERCROP's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BAYERCROP is overvalued based on its PB Ratio (10.5x) compared to the IN Chemicals industry average (1.1x).


Next Steps

Future Growth

How is Bayer CropScience forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.4%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bayer CropScience has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Bayer CropScience performed over the past 5 years?

1.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BAYERCROP has high quality earnings.

Growing Profit Margin: BAYERCROP's current net profit margins (15.2%) are higher than last year (5.9%).


Past Earnings Growth Analysis

Earnings Trend: BAYERCROP's earnings have grown by 1.8% per year over the past 5 years.

Accelerating Growth: BAYERCROP's earnings growth over the past year (293%) exceeds its 5-year average (1.8% per year).

Earnings vs Industry: BAYERCROP earnings growth over the past year (293%) exceeded the Chemicals industry -2.1%.


Return on Equity

High ROE: BAYERCROP's Return on Equity (23%) is considered high.


Next Steps

Financial Health

How is Bayer CropScience's financial position?


Financial Position Analysis

Short Term Liabilities: BAYERCROP's short term assets (₹30.1B) exceed its short term liabilities (₹11.4B).

Long Term Liabilities: BAYERCROP's short term assets (₹30.1B) exceed its long term liabilities (₹1.2B).


Debt to Equity History and Analysis

Debt Level: BAYERCROP's debt to equity ratio (0.06%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if BAYERCROP's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: BAYERCROP's debt is well covered by operating cash flow (44393.3%).

Interest Coverage: BAYERCROP earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Bayer CropScience current dividend yield, its reliability and sustainability?

1.50%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: BAYERCROP's dividend (1.5%) is higher than the bottom 25% of dividend payers in the Indian market (0.59%).

High Dividend: BAYERCROP's dividend (1.5%) is low compared to the top 25% of dividend payers in the Indian market (2.38%).


Stability and Growth of Payments

Stable Dividend: BAYERCROP's dividends per share have been stable in the past 10 years.

Growing Dividend: BAYERCROP's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (19%), BAYERCROP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average management tenure


CEO

Duraiswami Narain (57 yo)

1.75yrs

Tenure

₹140,650,000

Compensation

Mr. Duraiswami Narain has been Vice Chairman, Managing Director and CEO of Bayer CropScience Limited since December 1, 2018 and as its Executive Director since October 23, 2018. Mr. Narain served as Vice P ...


CEO Compensation Analysis

Compensation vs Market: Duraiswami's total compensation ($USD1.91M) is above average for companies of similar size in the Indian market ($USD819.50K).

Compensation vs Earnings: Duraiswami's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Duraiswami Narain
Vice Chairman1.75yrs₹140.65mno data
Rolf Hoffmann
CFO & Executive Director1.25yrs₹67.30mno data
Nikunjkumar Savaliya
Company Secretary & Compliance Officer0.67yr₹3.84mno data
Anil Jain
VP of Marketing & Co-operationsno data₹4.43mno data
Ajit Sawant
Head of Manufacturingno data₹2.71mno data
Bernd Lohmann
Head of BBS AP ODCno data₹23.42mno data
Mathias Kremer
Head of Strategy & Portfolio Management5.25yrsno datano data
Joerg Rehbein
Head of Bayer CropScienceno datano datano data
Pravin Trama
General Manager of Zonal Accountsno data₹2.63mno data
Asif Tanweer
General Manager of Business Development & Stewardship35.92yrs₹2.70mno data
Shivkumar Sudan
Vice President of Site Servicesno data₹2.78mno data
Ajit Tendulkar
General Manager of Co-operationsno data₹2.43mno data

1.8yrs

Average Tenure

61yo

Average Age

Experienced Management: BAYERCROP's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Duraiswami Narain
Vice Chairman1.75yrs₹140.65mno data
Rolf Hoffmann
CFO & Executive Director1.25yrs₹67.30mno data
Pankaj Patel
Non-Executive Independent Chairman4yrs₹1.89mno data
Sekhar Natarajan
Non-Executive & Independent Director0.92yr₹220.00k0.0011%
₹ 3.2m
Jens Hartmann
Non-Executive & Non-Independent Director1.58yrs₹18.91mno data
Thomas Hoffmann
Non-Executive Non-Independent Director1yr₹39.14mno data
Ketaki Bhagwati
Non-Executive Independent Director1.67yrs₹740.00kno data

1.6yrs

Average Tenure

56yo

Average Age

Experienced Board: BAYERCROP's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.9%.


Top Shareholders

Company Information

Bayer CropScience Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bayer CropScience Limited
  • Ticker: BAYERCROP
  • Exchange: NSEI
  • Founded: 1958
  • Industry: Fertilizers and Agricultural Chemicals
  • Sector: Materials
  • Market Cap: ₹300.561b
  • Shares outstanding: 50.11m
  • Website: https://www.bayer.in

Number of Employees


Location

  • Bayer CropScience Limited
  • Bayer House
  • Central Avenue
  • Thane
  • Maharashtra
  • 400 607
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
506285BSE (Mumbai Stock Exchange)YesEquity SharesININRJul 2001
BAYERCROPNSEI (National Stock Exchange of India)YesEquity SharesININRJul 2001

Biography

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India. It also provides pharmaceutical produ ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/25 20:16
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.